[{"NetIncomeLossConverted_1_Q3_USD":-194745000.0,"NetIncomeLossConverted_3_Q3_USD":-418821000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":-315158000.0,"CommonStockSharesOutstanding_0_Q3_shares":66339000.0,"StockholdersEquity_0_Q3_USD":1523021000.0,"EarningsPerShareBasic_1_Q3_USD":-2.94,"EarningsPerShareBasic_3_Q3_USD":-6.89,"Assets_0_Q3_USD":1945484000.0,"CommonStockSharesConverted_0_Q3_shares":66339000.0,"RevenuesConverted_1_Q3_USD":19273000.0,"RevenuesConverted_3_Q3_USD":240026000.0,"Ticker":"BLUE","CIK":"1293971","name":"BLUEBIRD BIO, INC.","OfficialName":"bluebird bio Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"301448421.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20201104"}]